Biomarin Pharmaceutical Inc (BMRN)

96.03
NASDAQ : Health Care
Prev Close 96.03
Day Low/High 0.00 / 0.00
52 Wk Low/High 62.12 / 118.48
Avg Volume 1.79M
Exchange NASDAQ
Shares Outstanding 163.47M
Market Cap 15.86B
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Biotech Stock Mailbag: Sarepta Therapeutics Approval Edition

Biotech Stock Mailbag: Sarepta Therapeutics Approval Edition

TheStreet's Adam Feuerstein answers reader questions about Sarepta Therapeutics and its newly approved drug Exondys 51 for Duchenne muscular dystrophy.

These 5 Biotech Stocks Are Ready for a Volatility Break

These 5 Biotech Stocks Are Ready for a Volatility Break

The squeeze is on these stocks, and they are poised for volatile moves.

BioMarin Announces Two Oral And 16 Poster Presentations At Society For The Study Of Inborn Errors Of Metabolism 2016 Annual Meeting

BioMarin Announces Two Oral And 16 Poster Presentations At Society For The Study Of Inborn Errors Of Metabolism 2016 Annual Meeting

Oral Presentations Include Updated Long-Term Data from Extension Study of Brineura™ (Cerliponase Alfa) in Children with CLN2 Disease, and Long-Term Safety and Efficacy Data of Pegvaliase in Adults with PKU

Forbes Ranks BioMarin 10th Most Innovative Company In The World

Forbes Ranks BioMarin 10th Most Innovative Company In The World

For the third consecutive year, BioMarin ranks in top 10 on list

BioMarin (BMRN) Stock Surges on Takeover Speculation

BioMarin (BMRN) Stock Surges on Takeover Speculation

BioMarin (BMRN) stock was trading sharply higher this morning after Pfizer (PFE) beat out Sanofi (SNY) to purchase Medivation (MDVN).

Facebook Stands Out and FormFactor Has a Good Start

Facebook Stands Out and FormFactor Has a Good Start

Overall, this is still a good environment for stock picking.

Cramer: Companies Are Issuing a Lot of Paper

Cramer: Companies Are Issuing a Lot of Paper

They're striking while the iron is hottest to raise money, reduce debt.

BioMarin (BMRN) Stock Tumbles in After-Hours Trading on Public Offering

BioMarin (BMRN) Stock Tumbles in After-Hours Trading on Public Offering

BioMarin (BMRN) stock is trading lower after the market close after announcing a public offering of common stock.

Trade-Ideas: Biomarin Pharmaceutical (BMRN) Is Today's Post-Market Leader Stock

Trade-Ideas: Biomarin Pharmaceutical (BMRN) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Biomarin Pharmaceutical (BMRN) as a post-market leader candidate

Cramer: What Are You Thinking? It Should Be Long Term

Cramer: What Are You Thinking? It Should Be Long Term

That may be the best way to get through the notorious month of August.

Biomarin Hemophilia Gene Therapy Advances on Strong Study Results

Biomarin Hemophilia Gene Therapy Advances on Strong Study Results

BMN 270 is one of the most important drugs in Biomarin's research pipeline and key driver of future revenue and earnings.

Roche Beats First-Half Forecasts as Cancer Drug Sales Rise

Roche Beats First-Half Forecasts as Cancer Drug Sales Rise

The Swiss pharmaceuticals company confirms a forecast for full-year sales to increase in the low to mid-single digits, and for earnings per share to grow faster than revenue.

3 Stocks Driving The Drugs Industry Higher

3 Stocks Driving The Drugs Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Cramer: 11 Reasons Why the Market Turned

Cramer: 11 Reasons Why the Market Turned

All of these add up to a level of insecurity on the part of sidelined money.

Biomarin Pharmaceutical (BMRN) Highlighted As Storm The Castle Stock

Biomarin Pharmaceutical (BMRN) Highlighted As Storm The Castle Stock

Trade-Ideas LLC identified Biomarin Pharmaceutical (BMRN) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate

Closing Bell: Humana Slumps on Deal Worries; U.S. Stocks Mixed

Closing Bell: Humana Slumps on Deal Worries; U.S. Stocks Mixed

A sharp selloff in crude kept stocks mostly in the red, though optimism ahead of Friday's jobs reports kept losses to a minimum on Thursday.

BioMarin (BMRN) Stock Soars on Takeover Speculation

BioMarin (BMRN) Stock Soars on Takeover Speculation

BioMarin (BMRN) stock is trading sharply higher this morning following reports that Roche (RHHBY) could pursue a takeover.